ovarian carcinoma trang 2 tải miễn phí từ TAILIEUCHUNG

"ovarian carcinoma" trang 2 - tải miễn phí từ Tailieuchung

Combination of lutetium-177 labelled antiL1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: A novel combination against human ovarian carcinoma

Combination of lutetium-177 labelled antiL1CAM antibody chCE7 with the clinically relevant protein kinase inhibitor MK1775: A novel combination against human ovarian carcinoma

14 35 1

Demethylation of HIN-1 reverses paclitaxelresistance of ovarian clear cell carcinoma through the AKT-mTOR signaling pathway

Demethylation of HIN-1 reverses paclitaxelresistance of ovarian clear cell carcinoma through the AKT-mTOR signaling pathway

12 50 1

High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma

High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma

8 19 1

The role of RhoC in epithelial-to-mesenchymal transition of ovarian carcinoma cells

The role of RhoC in epithelial-to-mesenchymal transition of ovarian carcinoma cells

12 26 1

MicroRNA profile of paclitaxel-resistant serous ovarian carcinoma based on formalin-fixed paraffin-embedded samples

7 43 1

Establishment and verification of the nomogram that predicts the 3-year recurrence risk of epithelial ovarian carcinoma

Establishment and verification of the nomogram that predicts the 3-year recurrence risk of epithelial ovarian carcinoma

9 30 1

Morphologic and molecular correlates of EZH2 as a predictor of platinum resistance in high-grade ovarian serous carcinoma

Morphologic and molecular correlates of EZH2 as a predictor of platinum resistance in high-grade ovarian serous carcinoma

14 17 1

Fibrinogen/albumin ratio as a promising predictor of platinum response and survival in ovarian clear cell carcinoma

Fibrinogen/albumin ratio as a promising predictor of platinum response and survival in ovarian clear cell carcinoma

10 27 3

Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: A retrospective analysis

Potential efficacy of weekly low-dose administration of bevacizumab as a combination therapy for platinum-resistant ovarian carcinoma: A retrospective analysis

7 8 1

Ovarian teratoma in a woodchuck (Marmota monax) with hepatocellular carcinoma: Radiologic and pathologic features

Ovarian teratoma in a woodchuck (Marmota monax) with hepatocellular carcinoma: Radiologic and pathologic features

7 7 1

CAISMOV24, a new human low-grade serous ovarian carcinoma cell line

CAISMOV24, a new human low-grade serous ovarian carcinoma cell line

12 32 1

Prognostic impact of platinum sensitivity in ovarian carcinoma patients with brain metastasis

Prognostic impact of platinum sensitivity in ovarian carcinoma patients with brain metastasis

8 67 0

Metachronous ovarian endometrioid carcinomas in a patient with a PTEN variant: Case report of incidentally detected Cowden syndrome

Metachronous ovarian endometrioid carcinomas in a patient with a PTEN variant: Case report of incidentally detected Cowden syndrome

5 66 0

Fertility-sparing surgery and oncologic outcome among patients with early-stage ovarian cancer propensity score- matched analysis

Fertility-sparing surgery and oncologic outcome among patients with early-stage ovarian cancer propensity score- matched analysis

7 65 0

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stemlike cells that predicts chemoresistance and poor prognosis

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stemlike cells that predicts chemoresistance and poor prognosis

11 86 1

Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube

Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube

12 48 1

GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer

GDF15 predict platinum response during first-line chemotherapy and can act as a complementary diagnostic serum biomarker with CA125 in epithelial ovarian cancer

10 55 1

High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy

High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy

9 36 1

MPO density in primary cancer biopsies of ovarian carcinoma enhances the indicative value of IL-17 for chemosensitivity

MPO density in primary cancer biopsies of ovarian carcinoma enhances the indicative value of IL-17 for chemosensitivity

8 59 1

Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer

Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer

16 42 1

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.